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Abstract
Purpose We investigated the effect of dietary fats on the incorporation of saturated (SAFAs) and monounsaturated dietary 
fatty acids (MUFAs) into plasma phospholipids and the regulation of the expression of lipid-metabolizing enzymes in the 
liver.
Methods Mice were fed different diets containing commonly used dietary fats/oils (coconut fat, margarine, fish oil, sunflower 
oil, or olive oil) for 4 weeks (n = 6 per diet group). In a second experiment, mice (n = 6 per group) were treated for 7 days with 
synthetic ligands to activate specific nuclear hormone receptors (NHRs) and the hepatic gene expression of CYP26A1 was 
investigated. Hepatic gene expression of stearoyl-coenzyme A desaturase 1 (SCD1), elongase 6 (ELOVL6), and CYP26A1 
was examined using quantitative real-time PCR (QRT-PCR). Fatty acid composition in mouse plasma phospholipids was 
analyzed by gas chromatography (GC).
Results We found significantly reduced hepatic gene expression of SCD1 and ELOVL6 after the fish oil diet compared 
with the other diets. This resulted in reduced enzyme-specific fatty acid ratios, e.g., 18:1n9/18:0 for SCD1 and 18:0/16:0 
and 18:1n7/16:1n7 for ELOVL6 in plasma phospholipids. Furthermore, CYP26A1 a retinoic acid receptor-specific target 
was revealed as a new player mediating the suppressive effect of fish oil-supplemented diet on SCD1 and ELOVL6 hepatic 
gene expression.
Conclusion Plasma levels of MUFAs and SAFAs strongly reflect an altered hepatic fatty acid-metabolizing enzyme expres-
sion after supplementation with different dietary fats/oils.
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Abbreviations
SCD1  Stearoyl-Coenzyme A desaturase 1
ELOVL6  Elongase 6
MUFA  Monounsaturated fatty acid
SAFA  Saturated fatty acid
CYP26A1  Cytochrome P450 26A1
RXR  Retinoid X receptor
RAR  Retinoic acid receptor
Introduction
Fatty acids of nutritional relevance can be grouped as 
saturated fatty acids (SAFAs), monounsaturated fatty 
acids (MUFAs), and polyunsaturated fatty acids (PUFAs). 
These fatty acids are found in commonly consumed dietary 
fats such as coconut fat, rich in SAFAs; olive oil, rich in 
MUFAs [mainly oleic acid (OLA, 18:1n9)]; fish oil, rich 
in n3-PUFAs [mainly eicosapentaenoic acid (EPA, 20:5n3) 
and docosahexaenoic acid (DHA, 22:6n3)]; sunflower oil, 
rich in n6-PUFAs [mainly linoleic acid (LA, 18:2n6)]; and 
margarine, a mix of n6-PUFAs, MUFAs, and SAFAs.
Current dietary recommendations for chronic disease pre-
vention are to focus on the quality of dietary fat consumed 
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favoring MUFA and PUFA sources while limiting SAFA-
rich diets [1–3]. However, high intake of n6-PUFAs results 
in a shift of the n3/n6 PUFA ratio towards a more pro-
nounced n6-PUFAs ratio, which has been associated with 
the pathogenesis of various chronic inflammatory diseases 
[4]. Another alternative to reduce SAFA intake is consump-
tion of margarine with a higher PUFAs’ and MUFAs’ con-
tent; however, the benefits of margarine consumption are 
not conclusive [5–7]. Thus, a better understanding of the 
roles fatty acids play on mechanisms underpinning health 
and disease is needed.
Besides providing an energy source for metabolic pro-
cesses, fatty acids have the potential to act as regulators of 
gene expression of enzymes in lipid homeostasis, fatty acid 
metabolism for energy homeostasis, and inflammation via 
nuclear hormone receptor (NHR)-mediated signaling [8]. 
Fatty acids, as well as specific synthetic ligands can acti-
vate NHR-mediated signaling such as retinoid X receptor 
(RXR)-, liver X receptor (LXR)-, peroxisome proliferator-
activated receptors (PPARs)-, and retinoic acid receptor 
(RAR)-mediated signaling. These receptors are major regu-
lators of genes associated with fat and energy metabolism 
[9–13].
A further important fate of essential fatty acids is their 
incorporation into phospholipids, which are key components 
of cell membranes [8, 14]. In humans, the phospholipid fatty 
acid composition is well associated with dietary fat intake 
[15–17]. The composition of phospholipids adapts depend-
ing of the type of dietary fatty acids consumed because of 
a constant turnover. This adaptation following fatty acid 
change could also alter the functionality and stability of 
affected cellular membranes [8, 18]. The availability of fatty 
acids to be incorporated into phospholipids also depends on 
the enzymatic activity of fatty acid-metabolizing enzymes 
[19].
The enzymes stearoyl-desaturase 1 (SCD1) and elon-
gase 6 (ELOVL6) are key regulators of MUFA and SAFA 
content in phospholipids [20, 21]. SCD1 desaturates stearic 
acid (STE, 18:0) or palmitic acid (PAL, 16:0) to 18:1n9 or 
palmitoleic acid (PAM, 16:1n7), respectively. ELOVL6 fur-
ther elongates 16:0–18:0 and 16:1n7 to vaccenic acid (VAC, 
18:1n7) [21]. Our previous studies in mice have shown that 
diet modulates the hepatic gene expression of SCD1. A diet 
rich in sunflower oil, and its major fatty acid constituents 
(n6-PUFAs) was an effective suppressor of the hepatic SCD1 
and ELOVL6 expression [22]. This suppression was also 
observed in phospholipid composition concomitantly with 
a significant reduction of their metabolic products measured 
in cellular membranes of liver tissue, in particular MUFAs 
[22]. The mechanism of suppression of SCD1 and ELOVL6 
by dietary fats with a high n6-PUFA content is still not fully 
understood, while it is well known that dietary n3-PUFAs 
also have a pronounced suppressive effect on the expression 
of these enzymes [23]. Regulation of the gene expression of 
SCD1 and ELOVL6 requires activation of RXR, a nuclear 
hormone receptor activated mainly by forms of vitamin A 
[24–26].
A novel theory is that CYP26A1, a well-known target 
gene of RAR-mediated signaling [27], is also implicated as 
a feedback mechanism in degradation of the endogenous 
ligands of the RARs, all-trans-retinoic acid towards less 
active hydroxy-/oxo-retinoic acids [27, 28]. The clearance 
of the endogenous RXR ligand [29] is likely also due to 
CYP26A1, an enzyme induced by 22:6n3, one of the main 
n3-PUFAs in fish oil [29, 30]. As a logical consequence, the 
activity of RXR is dependent on the availability of its natural 
derived ligands, which  in turn is regulated by the enzymatic 
activity of CYP26A1. These mechanisms could explain the 
suppressive effect of fish oil on the gene expression of SCD1 
and ELOVL6 [31], but this needs testing.
The aim of this study was (1) to determine the impact of 
nutritionally relevant dietary fats (coconut fat, margarine, 
olive oil, sunflower oil, and fish oil) on the hepatic gene 
expression of major fat metabolizing enzymes and on ratios 
and amounts of major fatty acids present in plasma; (2) to 
evaluate the hepatic expression of major fat metabolizing 
enzymes SCD1 and ELOVL6 and their activity represented 
by major substrate vs. product ratios; and (3) to investigate 
the hepatic gene expression of CYP26A1 after treatment 
with synthetic ligands of specific nuclear hormone recep-
tors (NHRs) such as liver X receptor (LXR), peroxisome 
proliferator-activated receptors (PPARs), RXR, and RARs. 
CYP26A1 is considered as a possible candidate for indi-
rect regulation of the hepatic gene expression of SCD1 and 
ELOVL6. We hypothesized that these mechanisms are mod-
ulated by retinoid-mediated signaling.
Materials and methods
Animal experiments were performed at the Laboratory Ani-
mal Core Facility of the University of Debrecen (Debre-
cen, Hungary) in accordance with the ethical guidelines of 
Hungary. Ethical approval was obtained from the Hungarian 
Animal Experimental Scientific Ethics Council in Budapest 
(registration 25/2006/DE MÁB). The Animal Experimenta-
tion Commission of University of Debrecen also approved 
the experiment.
Animal studies
Six-to-eight-week-old female standard C57BL6 (Strain 
Code 027) mice, purchased from Charles River (Budapest, 
H), were first fed ad libitum for 2 weeks with regular chow 
(VRF1, Altromin GmbH, Lage, D).
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Dietary fats and oil supplementation study
After the acclimatization period of 2 weeks, the animals 
were divided into five groups (total n = 30, 6 animals per 
diet group) and were assigned to each receive a different 
type of dietary fat for 4 weeks. The sample size was based 
on our previous experiments that tested the effect of ligand 
and dietary fats on SCD1 expression [22, 24]. These studies 
were powered, 99% and 72%, respectively, to detect a five- 
and threefold increase in SCD1 expression in experimental 
vs. control conditions with a level of p < 0.05.
Oil and fat supplementation diets
The experimental diets were formulated according to Bonilla 
et al. [32] and contained 415 g/kg diet (41.5%) wheat starch 
(Weizenstärke FOODSTAR, provided by Kröner-Stärke 
Ibbenbüren, D), 280 g/kg diet (28.0%) sucrose (purchased 
from a local supermarket), 180 g/kg diet (18.0%) casein from 
bovine milk (purchased from Sigma-Aldrich, Budapest, H), 
and 20 g/kg diet (2%) cellulose VIVAPUR (provided by JRS 
Pharma GmbH & Co. KG, Rosenberg, D). The content of 
minerals was 45 g/kg diet (4.5%) (Mineral-Spurenelemente-
Vormischung C1000). The vitamin content was 10 g/kg diet 
(1%) (Vitamin-Vormischung C1000) and was purchased 
from Altromin GmbH (Lage, D). The source of dietary fat in 
each experimental diet differed, while the content remained 
the same in each diet at 50 g fat/kg diet (5.0%) which is 
considered a normal fat content in laboratory animal-based 
feeding studies [32]. The fat sources were sunflower oil, fish 
oil, coconut fat, and olive oil (provided by Henry Lamotte, 
Bremen, D) and margarine (purchased from a local super-
market). The carbohydrate/protein/fat ratio in percent was 
69.5%/18%/5%, and other nutrients made up the remaining 
7.5%. Table 1 displays the fatty acid composition of each 
diet. The composition of fatty acids for all dietary fats and of 
phospholipids was analyzed by GC. All values were normal-
ized to coconut fat (= 1) to compare diet groups with each 
other and to compare GC values of diet and phospholipids 
to each other.
Nuclear hormone receptor‑specific ligand study [24]
After the acclimatization period of 2 weeks, animals (total 
n = 42, 6 animals per treatment group, 7 treatment groups 
including vehicle) were gavaged daily for 1 week with 
nuclear hormone receptor-specific synthetic ligands dis-
solved in 25% Cremophor EL (Sigma-Aldrich, Budapest, 
H)/water (v/v). The base diet of these animals was standard 
chow (VRF1, Altromin, D). The vehicle (Cremophor EL) 
was applied at 5 ml/kg body weight (b. w.). Rosiglitazone 
a PPARγ ligand was bought from Biomol (Butler Pike, 
USA), applied dosage 3 mg/kg b.w. [33] and LG268 a RXR 
ligand, applied dosage 30 mg/kg b.w. [34] was a gift from 
Ligand Pharmaceuticals (San Diego, Calif., USA). AM580 
(RAR ligand, applied dosage 10 mg/kg b.w.) [35], GW7647 
(PPARα ligand, applied dosage 3 mg/kg b.w.) [36], and 
GW0742 (PPAR β/δ ligand, applied dosage 5 mg/kg b.w.) 
[37], were purchased from Biotrend Chem. GmbH (Köln, 
D) and T0901317 (LXR ligand, applied dosage 20 mg/kg 
b.w.) [38] from Cayman Chemical Company (Tallinn, EST).
Animal handling
All mice had free access to water and food for the duration 
of the experiment. They were kept at 22 °C room tempera-
ture with a 12 h day/night cycle. All animals were killed by 
anaesthesia with halothane. Blood collection was carried out 
by cardiac puncture. The blood was centrifuged for 10 min 
and plasma was stored at − 80 °C. The mice were dissected, 
and liver samples were weighed and immediately frozen in 
liquid nitrogen and later stored at − 80 °C.
RNA isolation from liver and QRT‑PCR
Total RNA was isolated from liver and quantified by QRT-
PCR (quantitative real-time PCR). Samples of liver tissue 
Table 1  Composition of selected fatty acids of experimental diets 
analyzed by GC and displayed as weight %
COC coconut fat, MAR margarine, OLI olive oil, SUN sunflower oil, 
FIS fish oil
COC MAR OLI SUN FIS
SAFA 93.35 31.34 15.24 11.59 31.58
16:0 18.21 21.24 11.9 6.47 20.56
18:0 20.47 3.51 2.7 4.07 4.11
MUFA 2.43 44.58 73.56 19.98 24.77
16:1n7 0.06 0.24 1.21 0.02 8.3
18:1n7 0.1 1.92 1.79 0.47 3.22
18:1n9 2.16 40.89 70.4 19.44 10.51
20:1n9 0.08 0.85 0.17 0.05 1.82
n6-PUFA 3.7 18.97 10.63 68.17 5.94
18:2n6 3.23 18.69 10.52 67.86 3.51
18:3n6 < 0.001 0.01 < 0.001 < 0.001 0.26
20:3n6 < 0.001 < 0.001 < 0.001 0.04 0.19
20:4n6 < 0.001 0.02 < 0.001 0.06 1.02
22:4n6 0.02 0.02 < 0.001 < 0.001 0.11
22:5n6 < 0.001 0.03 < 0.001 < 0.001 0.46
n3-PUFA 0.32 5.03 0.49 0.20 37.14
18:3n3 0.29 4.79 0.45 0.17 1.29
18:4n3 < 0.001 0.14 0.02 < 0.001 3.09
20:5n3 < 0.001 0.03 0.02 0.03 16.11
22:5n3 0.02 < 0.001 < 0.001 < 0.001 2.77
22:6n3 0.02 0.02 < 0.001 0 13.72
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(50 mg) were homogenized in Trizol (10 mg tissue/100 µl 
Trizol, Sigma-Aldrich, Budapest, H) and extracted with 
chloroform (20 µl/100 µl Trizol). The aqueous phase was 
mixed with 700 µl of ethanol (70% v/v) and loaded on the 
RNA isolation column (GenElute Mammalian Total RNA 
Miniprep Kit, Sigma-Aldrich, Budapest, Hungary). RNA 
was isolated from tissue according to the protocol of Sigma-
Aldrich and eluted in nuclease free water. Concentration and 
purity of RNA were measured by Nanodrop (Thermo, Buda-
pest, Hungary). cDNA was obtained by reverse transcription 
(10 min 25 °C, 120 min 42 °C, 5 min 72 °C) and ampli-
fied via QRT-PCR (40 cycles: 12 s 94 °C, 45 s 60 °C, 60 s 
94 °C). The primer and probe for the expression analysis 
(Taq-Man-Gene Expression Assay) as well as the quantita-
tive real-time PCR detection system (ABI-PRISM, 7900HT 
Sequence Detection System) were purchased from Applied 
Biosystems (Budapest, Hungary). The expression of genes 
was normalized to cyclophilin A (house-keeping gene): 
primer 77“+”5´-CGA TGA CGA GCC CTTGG-3´, primer 
142”-“5´-TCT GCT GTC TTT GGA ACT TTGTC-3´, probe 
(69+ , 96 +): FAM-CGC GTC TCC TTC GAG CTG TTT GCA 
, quencher tetramethylrhodamine (TAMRA). The amplifica-
tion signal was detected and analyzed by the SDS2.1 pro-
gram from Applied Biosystems, Budapest, Hungary. The 
expression of the house-keeping gene was stable and was not 
influenced by dietary treatment. The hepatic gene expression 
of target genes SCD1, ELOVL6, and CYP26A1 was normal-
ized to coconut fat supplementation diet (= 1).
Fatty acid analysis by gas chromatography (GC)
Food and plasma samples were analyzed by GC. Frozen 
samples were thawed and the pentadecanoylphosphatidyl-
choline (L-α phosphatidylcholine, dipentadecanoyl, Sigma-
Aldrich, Budapest, Hungary) internal standard was added. 
Lipids were extracted by the addition of 3 ml chloroform and 
1 ml methanol according to the method of Folch [39]. The 
mixture was vortexed at 3000 rpm for 15 min. The lower 
layer was then aspirated into vials and evaporated under an 
 N2 stream. Lipid extracts were reconstituted in 70 µl chloro-
form and lipid classes were separated by thin-layer chroma-
tography (TLC). The solvent mix for TLC of plasma lipids 
was as follows: hexane: diethyl ether: chloroform: acetic 
acid (21:6:3:1, v/v). The bands were stained with dichlor-
ofluorescein and removed by scraping and transesterified 
in 1 ml of 3 N HCl in methanol solution (3 N methanolic 
HCl, Supelco, Budapest, H) at 84 °C for 45 min [40]. For 
plasma samples, the phospholipid fraction was analyzed 
after TLC separation. Fatty acids were analyzed by high-
resolution capillary GC using a Finnigan 9001 gas chroma-
tograph (Finnigan/Tremetrics Inc., Austin, TX, USA) with 
split injection (ratio 1:25), an automatic sampler (A200SE; 
CTC Analytic, Zwingen, CH, USA), and a flame ionization 
detector with a DB-23 cyanopropyl column of 40 m length 
(J&W Scientific, Folsom, CA, USA). The temperature pro-
gram was set to the following parameters: temperature of 
the injector at 80 °C/min up to 280 °C, temperature of the 
detector at 280 °C, temperature of the column area at 60 °C 
for 0.2 min, temperature increase by 40 °C/min up to 180 °C, 
5 min isothermal period, temperature increase by 1.5 °C/
min up to 200 °C, 8.5 min isothermal period, temperature 
increase by 40 °C/min up to 240 °C, and 13 min isothermal 
period. The constant linear velocity was 0.3 m/s (referred to 
100 °C). Peak identification was confirmed by comparison 
with authentic mixtures of weighed fatty acid methylesters 
(GLC-463: Nu-Chek Prep, Elysian, MN, USA; and Supelco 
37 FAME Mix: Supelco, Bellefonte, PA, USA). Individual 
fatty acid responses determined from weighed standards 
were used to calculate the percentage by weight for each 
fatty acid (between 12 and 24 carbon atoms) based on the 
area under the curve. Values were normalized to coconut 
fat (= 1) and compared with the other diet groups. The nor-
malized values of enzyme-specific fatty acids for SCD1 and 
ELOVL6 analyzed by GC are displayed for diet and phos-
pholipids. Normalization of values of the enzyme-specific 
fatty acid profile in diet and phospholipids enabled a direct 
comparison.
Graphical analysis
Network graphical analysis was created using the mixOmics 
package in R (3.5 version) [41]. The resulting color codes for 
the mouse data as well as the food data were incorporated 
into a self-constructed graphic representation.
Statistical analysis
Results are shown as mean and standard error of mean. The 
effect of diet (comparing all diet groups to each other) was 
analyzed using the Kruskal–Wallis test followed by paired 
analysis. All statistical analyses were done using SPSS 
(15.0) software (SPSS Inc., Chicago, USA). Statistically 
significance was accepted at p < 0.05.
Results
MUFA/SAFA content in phospholipids
Role of SCD1 on fatty acid composition
Concentrations of SCD1‑dependent fatty acids and specific 
fatty acid ratios measured in  diet The fatty acids of the 
SCD1 metabolic pathway (16:0, 16:1n7, 18:0, 18:1n9) in all 
diet groups were analyzed. Fatty acid comparisons between 
all diet groups showed that the highest amount of 16:0 was 
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found in the margarine diet, while the lowest amount was 
measured in the sunflower oil diet (Fig.  1a). The highest 
concentrations of 16:1n7 were measured in the fish oil diet 
and the lowest in the sunflower oil diet (Fig. 1a). For 18:0, 
the highest concentration was found in the coconut fat diet 
and the lowest in the olive oil diet (Fig.  1a). 18:1n9 was 
highest in the olive oil diet and lowest in the coconut fat 
diet (Fig. 1a). The ratio of substrates and products of SCD1 
was highest in the olive oil diet and lowest in the coconut fat 
diet (Fig. 1b). The ratio of 16:1n7/16:0 was highest in the 
fish oil diet and lowest in the coconut fat diet. The ratio of 
18:1n9/18:0 was highest in the olive oil diet and lowest in 
the coconut fat diet (Fig. 1c).
Effects of diets on the hepatic SCD1 expression The hepatic 
gene expression of SCD1 was highest after the margarine 
diet and lowest after the fish oil diet (Fig. 1d). Significant 
differences could be observed in the hepatic gene expres-
sion between the different diets with statistically significant 
effects between the fish oil and coconut fat, margarine, and 
olive oil diets (p < 0.05). Furthermore, the hepatic gene 
expression of SCD1 was significantly higher after the mar-
garine fat diet compared with the olive oil and fish oil diet 
(p < 0.05).
Relative concentrations of  fatty acids and  fatty acid ratios 
in  phospholipids In plasma phospholipids, 16:0 and 18:0 
were found in highest concentrations in animals fed the 
fish oil diet, while the lowest concentrations were found in 
animals which consumed the margarine diet (Fig. 1e). Lev-
els of 18:1n9 and 16:1n7 were highest in animals fed the 
margarine diet and lowest after the sunflower oil and fish 
oil diet (Fig. 1e). The combined substrate/product ratio of 
SCD1 was highest after the margarine diet; this was sig-
nificantly higher than for olive oil, sunflower oil and fish oil 
diets (p < 0.05) (Fig. 1f). The lowest substrate/product ratio 
of SCD1 in phospholipids was for the fish oil diet group 
which was significantly different to the coconut fat, mar-
garine, and olive oil diets (p < 0.05). The specific ratios of 
16:1n7/16:0 and 18:1n9/18:0 were highest after the marga-
rine diet (Fig. 1g); the 18:1n9/18:0 ratio was significantly 
higher in the margarine diet compared with the sunflower 
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Fig. 1  a SCD1 dependent fatty acids in diets, in weight/weight %, b 
fatty acid ratios (products 16:1n7, 18:1n9 vs. substrates 16:0, 18:0) 
of SCD1) in experimental diets, c specific SCD1 ratios (16:1n7/16:0, 
18:1n9/18:0) of fatty acids in experimental diet groups, d) hepatic 
gene expression of SCD1, e SCD1 dependent fatty acids in phos-
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18:1n9 vs. substrates 16:0, 18:0) in phospholipids of experimental 
diet groups, g specific SCD1 ratios (16:1n7/16:0, 18:1n9/18:0) of 
fatty acids in phospholipids. Fatty acid composition of diet and phos-
pholipids in plasma was analyzed by GC. Hepatic gene expression 
of SCD1 was analyzed by QRT-PCR. All values were normalized to 
coconut diet representing 1 and statistical difference was accepted for 
p < 0.05, COC (C) coconut fat, MAR (M) margarine, OLI (O) olive 
oil, SUN (S) sunflower oil, FIS (F) fish oil
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and fish oil diets. The lowest ratio of 16:1n7/16:0 was found 
in the sunflower diet which was significantly lower com-
pared with the coconut fat and fish oil diets (p < 0.05). The 
lowest value of 18:1n9/18:0 was observed in the fish oil diet; 
this was significantly lower than the ratios observed in the 
coconut fat, margarine, and olive oil diets (Fig. 1g).
In summary, the relative concentrations of SAFAs 16:0 
and 18:0 as well as MUFAs 16:1n7 and 18:1n9 measured in 
the experimental diets were different from those measured in 
plasma phospholipids. Furthermore, the SCD1-specific fatty 
acid ratio of 18:1n9/18:0 detected in phospholipids, and to a 
lesser extent, the 16:1n7/16:0 ratio reflected the hepatic gene 
expression of this enzyme.
Role of ELOVL6 on fatty acid composition
Concentrations of  ELOVL6‑dependent fatty acids and  spe‑
cific fatty acid ratios measured in diet The main ELOVL6 
product 18:1n7 was found in the highest concentrations in 
the fish oil diet and lowest in the coconut fat diet (Fig. 2a). 
The summarized ratio of ELOVL6 substrates vs. products 
was highest in the coconut fat diet and lowest in the fish oil 
and margarine diets (Fig. 2b). The specific ratio of 18:0/16:0 
was highest in the coconut fat diet and lowest in the marga-
rine diet (Fig. 2c). The 18:1n7/16:1n7 ratio was highest in 
the sunflower oil and lowest in the fish oil diets (Fig. 2c).
Effects of  diets on  the  hepatic gene expression 
of  ELOVL6 The hepatic gene expression of ELOVL6 was 
significantly lower after the fish oil diet compared with the 
margarine and olive oil diets. Furthermore, there was a sig-
nificant difference between the high ELOVL6 expressions 
in the margarine diet compared with the olive oil supple-
mentation diet (Fig. 2d).
Relative concentrations of  fatty acids and  fatty acid ratios 
in phospholipids Concentrations of 18:0, 16:0, and 16:n7 in 
phospholipids were described previously for SCD1 (1.1.3.). 
The highest 18:1n7 fatty acid concentration in plasma phos-
pholipids was found in animals fed the coconut fat diet; 
all other diets revealed significantly lower 18:1n7 levels 
(p < 0.05). The lowest level of 18:1n7 was found in the fish 
oil supplementation group, which was significant lower 
compared with coconut fat, margarine and olive oil supple-
mentation group (p < 0.05, Fig. 2e). The ratio of substrates 
vs. products of ELOVL6 in plasma phospholipids was high-
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est in the coconut fat diet (significantly higher vs. margarine 
and fish oil diet) and lowest in plasma phospholipids of the 
fish oil diet (significantly lower compared with the coco-
nut and sunflower oil diet) (Fig. 2f). The ELOVL6-specific 
ratio of 18:0/16:0 was highest in plasma phospholipids of 
the sunflower oil supplementation group and lowest in the 
fish oil supplementation group (Fig. 2g). The 18:1n7/16:1n7 
ratio was highest after the olive oil supplementation diet 
(significantly higher compared with the margarine and fish 
oil diet groups) and lowest in the fish oil supplementation 
group (significant when compared with the coconut fat, 
olive oil, and sunflower oil diet groups (Fig. 2g).
In summary, the single fatty acids 16:0, 18:0, 16:1n7, and 
18:1n7 supplemented in the diet did not reflect the content in 
plasma phospholipids. The fatty acid ratios of plasma phos-
pholipids reflected the hepatic gene expression of ELOVL6 
only in the fish oil diet group (Fig. 2d, f).
Hepatic gene expression of CYP26A1
The hepatic gene expression of CYP26A1 was significantly 
higher in the fish oil diet compared with the margarine, olive 
oil, and sunflower oil diets (Fig. 3a). In addition, CYP26A1 
was significantly increased exclusively after administration 
of a specific RAR ligand and not by any other specific ligand 
of the nuclear hormone receptor family such as PPARα, β/δ 
or γ, RXR and LXR (Fig. 3b).
Discussion
We investigated the impact of supplementing diets with 
different sources of fat and oils and the effect of this sup-
plementation on the hepatic gene expression of major lipid-
metabolizing enzymes which control plasma phospho-
lipid composition. Our research question was to elucidate 
whether MUFA and SAFA contents in plasma phospholipids 
is affected by diet or by gene expression of metabolizing 
enzymes [8, 42]. For this purpose, we examined the hepatic 
gene expression of specific fatty acid-metabolizing enzymes 
SCD1 and ELOVL6 in the liver of mice and analyzed the 
fatty acid composition of diets and plasma phospholipids. 
To allow a comprehensive comparison between diets, we 
normalized all results for relative fatty acid content in the 
diet, hepatic gene expression, and phospholipid composi-
tion against the diet group supplemented with coconut fat. 
This allowed us to compare changes between the groups. We 
calculated product vs. substrate ratios specific for the lipid-
metabolizing enzymes in both diet and phospholipids, and 
these were displayed together with the hepatic gene expres-
sion of the metabolic enzyme.
SCD1 and ELOVL6 and their specific fatty acids 
in phospholipids
Our results clearly showed that the content of MUFAs and 
SAFAs in phospholipids is highly dependent on the hepatic 
gene expression of the lipid-metabolizing enzymes SCD1 
and ELOVL6 and to a lesser extent on the ingestion of 
MUFA or SAFA (summarized in Fig. 4a). We found that 
the ratio 18:1n9/18:0 highly reflects the hepatic expression 
of SCD1, however this was only partly observed in the ratio 
16:1n7/16:0. Our observation confirms previous findings in 
human plasma [43, 44]. In our study, 16:1n7/16:0 was fur-
ther directly affected by fatty acids highly present in the fish 
oil diet. This fish oil diet contained high amounts of 16:1n7 
and consumption leads to a high amount of 16:1n7 in plasma 
phospholipids in mice which could be an explanation for the 
elevated 16:1n7/16:0 ratio (Fig. 1a, e). In addition to this, 
we observed that in animals fed the fish oil diet, the hepatic 
expression of SCD1 was significantly lower compared with 
other dietary fats which explains the low levels of 18:1n9 
incorporated into plasma phospholipids and the reduced 
18:1n9/18:0 ratio. On the other hand, higher 18:1n9/18:0 
and 16:1n7/16:0 ratios were observed in phospholipids 
of animals fed the coconut fat and margarine diets. These 
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Fig. 3  a Hepatic gene expression of CYP26A1. All values were 
normalized to coconut diet representing 1, statistic difference was 
accepted for p < 0.05, COC (C)  coconut fat, MAR (M) margarine, 
OLI (O) olive oil, SUN (S) sunflower oil, FIS (F) fish oil. b Hepatic 
gene expression of CYP26A1 after administration of vehicle (VEH) 
and additional synthetic and specific ligands of the nuclear hormone 
receptor family [Pγ (PPARγ), Pβ (PPARβ/δ) or Pα (PPARα), RXR, 
and LXR]. Statistical difference was accepted for p < 0.05
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results highly reflect the increased hepatic gene expression 
of SCD1 following the coconut and margarine diets in com-
parison with those animals fed fish oil diet.
We also investigated specific fatty acid ratios in plasma 
18:0/16:0 and 18:n7/16:1n7, because they have the potential 
to reflect the ELOVL6 hepatic gene expression [21]. Knock-
out models of ELOVL6 have shown the importance of this 
enzyme for the elongation of fatty acids derived from diet or 
de novo fatty acid synthesis to provide sufficient amounts of 
18:0 and 18:1n9 in the liver of mice [21]. Thereby, specific 
fatty acid ratios of 18:0/16:0 and 18:n7/16:1n7 were sug-
gested by Matsuzaka et al. to reflect the ELOVL6 enzymatic 
reaction [21]. In one of our previous studies, we induced an 
overexpression of ELOVL6 in the liver by administration 
of specific ligands to activate the NHRs, LXR, and RXR, 
which induced the ELOVL6 hepatic gene expression lead-
ing further to an increase in the specific fatty acid ratios of 
ELOVL6 in liver and plasma [24]. In this study, we showed 
that feeding mice with fish oil, margarine, olive oil, and 
sunflower oil diets which contained high levels of 18:1n7 
(Fig. 2a) resulted in low plasma phospholipid levels of 
this specific fatty acid (Fig. 2e). This result was more pro-
nounced in the fish oil diet group, as the hepatic expression 
of ELOVL6 was significantly lower, which could further 
explain the low fatty acid ratio of 18:n7/16:1n7 observed 
in plasma phospholipids of this diet group. The low ratio of 
18:0/16:0 in phospholipids of the fish oil diet group which 
was observed seems to result from the low hepatic gene 
expression of ELOVL6. Other suppressing effects by diet on 
ELOVL6 gene expression have been previously reported by 
our group. High fat diets rich in n6-PUFAs also suppressed 
ELOVL6 hepatic gene expression in a dose-dependent man-
ner [22]. This suppression led to reduced enzymatic products 
of ELOVL6 in phospholipids [22].
Fig. 4  a Metabolic pathways 
of SCD1 (S1) and ELOVL6 
(E6) mediation of 16:0 and 
18:0–16:1n7, 18:1n7 and 
18:1n9 in plasma phospholipids 
and dietary fats effects. The 
supplemented dietary fat is 
shown as a shadow behind the 
individual fatty acid in plasma 
phospholipids. b Proposed 
mechanisms for fish oil sup-
plementation and modification 
of hepatic CYP26A1 expres-
sion and concomitant effects on 
SAFA to MUFA synthesis via 
SCD1 and ELOVL6 expres-
sion. COC coconut fat, MAR 
margarine, OLI olive oil, SUN 
sunflower oil, FIS fish oil
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The fish oil supplementation diet significantly reduced the 
hepatic gene expression of SCD1 and ELOVL6 in compari-
son with other sources of fat. This resulted in lower levels of 
MUFAs and higher levels of SAFAs in plasma phospholip-
ids (summarized in Fig. 4a). The depletion and down regula-
tion of SCD1 and ELOVL6 gene expression (indicating low 
levels of phospholipid MUFAs and high levels of SAFAs) 
might contribute to the protective mechanisms against diet-
induced obesity, hepatic steatosis, and/or type 2 diabetes, as 
was shown in SCD1 and ELOVL6 knock-out models [45, 
46]. This postulates different beneficial effects of fish oil/
n3-PUFA diets besides functioning as precursors for anti-
inflammatory and pro-resolving lipid mediators [21, 23, 47].
Gene regulation connecting the fatty acid 
and retinoid pathway
Although the hepatic gene expression of SCD1 and ELOVL6 
by dietary supplemented fat and oils has been well investi-
gated, it is still not clear why a fish oil diet rich in n3-PUFAs 
(20:5n3, 22:6n3) and in n6-PUFAs results in a comparable 
low hepatic expression of these enzymes [31, 48–50]. For 
SCD1 and ELOVL6, we previously showed that the applica-
tion of a synthetic LXR or RXR ligand can strongly induce 
hepatic SCD1 and ELOVL6 expression [24]. A retinoic acid 
is proposed as an endogenous RXR ligand [51], which our 
group found recently to be most likely 9-cis-13,14-dihydro-
retinoic acid (9CDHRA) [26, 52]. Afterwards, retinoic acid 
can be oxidized by the CYP26A1 and becomes inactive for 
receptor binding [29, 53]. Interestingly, 22:6n3 also has an 
inductive effect on the gene expression of CYP26A1 [30] via 
an unknown mechanism of action. We found that the fish oil-
supplemented diet high in 22:6n3 strongly induced hepatic 
gene expression of CYP26A1 (Fig.  3a). The increased 
CYP26A1 expression might further catabolize 9-cis retinoic 
acid (9CRA) and 9CDHRA and reduce their availability as 
endogenous RXR ligand [26]. This might lead to reduced 
RXR-mediated signaling which may suppress hepatic 
SCD1 and ELOVL6 gene expression as observed in our 
experiment. The application of synthetic ligands to activate 
NHR showed that just the specific RAR ligand was able to 
strongly and significantly induce hepatic CYP26A1 expres-
sion (Fig. 3b). It seems likely that fish oil supplementation 
may mediate RAR-supported CYP26A1 expression via 
still unknown pathways (Fig. 4b). The activation of RAR-
mediated signaling by a fish oil diet rich in n3-PUFAs may 
thereby be a major regulator of gene expression of the fat 
metabolizing target genes SCD1 and ELOVL6. Our findings 
suggest a potential new and important regulatory mecha-
nism in which a fish oil diet rich in n3-PUFAs can alter lipid 
metabolism and might explain protective effects of PUFAs in 
obesity and diabetes [23] (summarized in Fig. 4b). We have 
used a mouse model with hepatic fatty acid-metabolizing 
enzymes that are also expressed in human liver [54–57]; for 
example, PPARs hepatic expression is similar in mice and 
humans [58]. PPARγ expression and modulation is crucial 
in adipogenesis, lipid metabolism, and inflammation. PPARγ 
expression is modulated by dietary components belonging 
to the lipid family which undergoes extensive metabolism in 
the liver and acts as an inductor or suppressor of its expres-
sion [59]. The interaction between dietary fat type, circulat-
ing fatty acid patterns, and hepatic enzyme expression is 
likely to result in altered liver metabolism. This might have 
other major metabolic implications. For example, fish oil 
supplementation compared to olive oil increased beta-oxi-
dation rate resisting the inhibitory effect of insulin which did 
not occur in olive oil supplementation. Fish oil also reduced 
fatty acid incorporation into triglycerides and secretion of 
VLDL triglycerides [60]. However, the applicability of our 
findings for humans remains speculative. We used different 
regimes of fat supplementation in controlled animal feeding 
studies which might not be relevant to human diets; thus, 
further studies using human cell lines, ex vivo human tis-
sues, or human dose relevant clinical supplementation trials 
are needed for translational purposes.
Conclusion
We found that the MUFA/SAFA contents in mouse plasma 
phospholipids are mainly reflected and likely directly regu-
lated by dietary stimuli altered hepatic gene expression of 
major lipid-metabolizing enzymes SCD1 and ELOVL6. In 
summary, MUFAs and SAFAs present in phospholipids are 
dependent on the transcriptional induction at hepatic gene 
expression level, and to lesser extent, these respond to die-
tary ingestion and further incorporation in the body.
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